The EIF2AK1 Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population engineered to disrupt the EIF2AK1 gene in the Jurkat human T lymphocyte cell line. This loss-of-function model is designed to enable investigation of the eukaryotic translation initiation factor 2-alpha kinase 1 (heme-regulated inhibitor, HRI) within the context of T cell leukemia. The polyclonal nature ensures population-level gene disruption, avoiding artifacts associated with clonal selection, and provides a robust platform for studying integrated stress response (ISR) signaling pathways in immune cells.
Jurkat cells, an immortalized T lymphocyte line derived from a patient with T cell acute lymphoblastic leukemia, serve as a widely used model for TCR signaling, leukemia biology, and stress responses. Their genetic tractability and well-characterized signaling networks make them ideal for CRISPR-based gene editing. This knockout model specifically targets the kinase responsible for sensing heme deficiency and proteotoxic stress, thereby enabling dissection of ISR dynamics in a leukemia-relevant cellular context.
EIF2AK1 (HRI) is a Ser/Thr kinase that acts as a critical sensor in the integrated stress response. It is activated by heme deficiency, oxidative stress, heat shock, and proteotoxic stress, and it phosphorylates its primary substrate, EIF2S1 (eIF2??) at Ser51. Phosphorylated eIF2?? attenuates global cap-dependent translation while selectively enhancing translation of ATF4, a transcription factor that induces downstream targets such as DDIT3 (CHOP) and PPP1R15A (GADD34), which together mediate stress adaptation or apoptosis. EIF2AK1 also interacts with molecular chaperones including HSP90 and HSP70, which modulate its stability and activation. This network represents a central regulatory hub controlling translational reprogramming under stress conditions.
In Jurkat T cells, the ISR plays a pivotal role in modulating cellular responses to oncogenic stress, therapeutic agents, and immune signaling. Disruption of EIF2AK1 in this line provides a unique tool for dissecting how leukemia cells integrate stress signals to sustain survival or undergo apoptosis. Since Jurkat cells express key components of the ISR, the knockout model enables precise assessment of EIF2AK1-dependent versus independent stress pathways. This is particularly relevant for understanding mechanisms of drug resistance in T-ALL and for identifying synthetic lethal interactions with chemotherapeutic agents that induce oxidative or proteotoxic stress.
Typical research applications include western blotting to confirm loss of EIF2AK1 protein and abrogation of stress-induced eIF2?? phosphorylation, RT-qPCR quantification of ATF4 and DDIT3 transcript induction, flow cytometry for Annexin V-based apoptosis assays under stresses such as arsenite or thapsigargin, and cell viability assays using MTT or ATP-lite readouts. This polyclonal knockout population is suitable for high-throughput screening of kinase inhibitors, evaluation of heme metabolism in T cells, and investigation of translational control in leukemia progression. For further information, please contact Ascent Research.
